Bainco International Investors’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$138K Sell
1,314
-2,186
-62% -$221K 0.02% 84
2020
Q3
$248K Hold
3,500
0.03% 81
2020
Q2
$225K Sell
3,500
-1,500
-30% -$82.1K 0.03% 76
2020
Q1
$150K Buy
+5,000
New +$115K 0.03% 83
2019
Q2
Sell
-11,000
Closed -$224K 83
2019
Q1
$224K Buy
+11,000
New +$204K 0.04% 79

Other funds holding MRNA

Bainco International Investors's MRNA Position: Q4 2020 in Review

Bainco International Investors reduced its Moderna (MRNA) stake by 62% in Q4 2020, selling an estimated $221K and leaving 1,314 shares worth $138K. The position accounts for 0.02% of the portfolio, ranked #84.

Bainco International Investors first reported a position in MRNA in Q1 2019 and has held it in 5 quarters since. The position peaked at $248K in Q3 2020. 718 funds tracked by Wall St. Rank hold MRNA as of Q4 2020.

  • Bainco International Investors held 1,314 shares of Moderna worth $138K as of Q4 2020.
  • Bainco International Investors sold 2,186 Moderna shares in Q4 2020, an estimated $221K.
  • Moderna made up 0.02% of Bainco International Investors's portfolio in Q4 2020, its #84 holding.
  • Bainco International Investors first reported a position in Moderna in Q1 2019 and has held it in 5 quarters since.
  • Bainco International Investors's Moderna position peaked at $248K in Q3 2020.
  • 718 funds tracked by Wall St. Rank held Moderna as of Q4 2020.

Based on Bainco International Investors's 13F filing for Q4 2020, filed 12 Jan 2021.